Piggy Bank: Experience the Semantic Web Inside Your Web Browser

The original publication is available at www.springerlink.com http://dx.doi.org/10.1007/11574620_31The Semantic Web Initiative envisions a Web wherein information is offered free of presentation, allowing more effective exchange and mixing across web sites and across web pages. But without substantial Semantic Web content, few tools will be written to consume it; without many such tools, there is little appeal to publish Semantic Web content. To break this chicken-and-egg problem, thus enabling more flexible information access, we have created a web browser extension called Piggy Bankthat lets users make use of Semantic Web content within Web content as users browse the Web. Wherever Semantic Web content is not available, Piggy Bank can invoke screenscrapers to restructure information within web pages into Semantic Web format. Through the use of Semantic Web technologies, Piggy Bank provides direct, immediate benefits to users in their use of the existing Web. Thus, the existence of even just a few Semantic Web-enabled sites or a few scrapers already benefits users. Piggy Bank thereby offers an easy, incremental upgrade path to users without requiring a wholesale adoption of the Semantic Web’s vision. To further improve this Semantic Web experience, we have created Semantic Bank, a web server application that lets Piggy Bank users share the Semantic Web information they have collected, enabling collaborative efforts to build sophisticated Semantic Web information repositories through simple, everyday’s use of Piggy Bank

Tardive Akathisia in an Adult on Long Term Metoclopramide

Metoclopramide is prescribed to subjects dealing with gastrointestinal issues like delayed gastric emptying, nausea, vomiting or loss of appetite. It is also used to treat chemotherapy and surgery related nausea and vomiting.  Although it is very effective in targeting stomach related illnesses, severe adverse drug reactions can occur in those who take metoclopramide.  This case report describes a 32-year-old female who suffered from tardive akathisia while being treated with long-term metoclopramide. Long term exposure to causative medication leads to evolution of Tardive akathisia and this can stay for a lifetime. It is important to restrict the exposure duration of triggering drug. Health care professionals and patients should be well aware of this neurological adverse event of metoclopramide

Soot and smoke emissions numerical evaluation for a direct injection (DI) diesel engine

The reduction of Diesel internal combustion engines emissions is one of the major concerns of the engines manufacturers. Despite the fact that the efficiency of the gas post-treatment systems has been significantly improved, decreasing the smoke and the soot from the cylinder inside remains a main research goal. This work is proposing a theoretical study on these pollutants formation for different kinds of direct injection methods. By dividing the in-cylinder injection the heat release characteristic could be modified, leading to different temperature and pressure levels. Using exhaust gas recirculation (EGR) the reduction of the gas temperatures might also be decreased, limiting NOx formation. To evaluate the level of the cylinder gas emissions formation a two-step procedure could be followed. First, by using a numerical calculation system the heat release characteristic can be highlighted concerning a Diesel engine with stratified injection; then, using an experimental relationship applying a large data base, the amount of the gas emissions can be subsequently provided. The authors propose some combinations between injection characteristics and EGR used fractions which could generate successfully results speaking in terms of NOx, soot and smoke formation

Polypropylene Compounds for PEM-Electrolyzer Plates: Materials, Processing Methods, and Analysis of the Materials

Titanium and graphite-filled composites together with a polymer, such as polypropylene, are a suitable material for bipolar plates in PEM electrolyser applications. Similar to pure titanium metals, titaninium and graphite composite plates have quite good properties when mixed with polypropylene (PP). The plates have relatively low electrical resistance and can withstand the aggressive electrochemical environment encountered in an electrolyser. The main challenges here are resistance to oxygen, hydrogen, and complete. The conditions in operation are extreme. Above all, the comparatively high voltage and the fact that pure water is used generally cause problems for the materials. Besides pure titanium, composite materials can also be used. This chapter summarizes the most important requirements for the titanium-PP composite material. This material is used for bipolar plates. This is the basis for the characterization methods of titanium-based bipolar plates. The modern PP-based composites and their general properties are described, with a focus on improved long-term stability. In this chapter, the material fillers such as titanium and graphitic powders are analysed. The last deals with the way the electrical conductivity of the materials is measured and with in situ operation

Demographic, clinical and pathological characterisation of patients with colorectal and anal cancer followed between 2013 and 2016 at Maputo Central Hospital, Mozambique

Publisher Copyright: © 2021 ecancer Global Foundation. All rights reserved.Purpose: The aim of this study was to investigate colorectal cancer (CRC) data and anal cancer data from Maputo Central Hospital (MCH), the largest hospital and a reference for oncological diseases in Mozambique, with the aim of characterising the disease profile in view to define an appropriate control programme. Methods: MCH records from the Pathology and Surgery Services and MCH Cancer Registry database were assessed to obtain retrospective clinical and pathologic data of patients with CRC or anal cancer admitted to and treated between 13 December 2013 and 23 March 2016. Results: The female gender was more prevalent (54.8%), even when anal cancers were excluded. Median age was 54 years (20 99). Most patients (51.6%) lived in the city of Maputo. The most common presenting symptom was found to be rectal bleeding. Adenocarcinoma was the most frequent histological type, and the most prevalent anatomical site was the rectum. Most of the cases were diagnosed at MCH in advanced stages. Colostomy was the most frequent surgical procedure and performed in 38.7% of the patients. Most cases of anal cancer occurred in human immunodeficiency virus-infected patients. Most patients had a poor prognosis due to advanced stage at first diagnosis. Conclusion: We observed an increase in cases of CRC and anal cancer in Mozambique and mostly diagnosed at advanced stages, which anticipates a dismal prognosis. Our data supports the urgent need of a comprehensive public health programme dedicated to solving this growing concern.publishersversionpublishe

Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma

Esophageal adenocarcinoma (EA) incidence has risen sharply in Western countries over recent decades. Local and systemic inflammation, operating downstream of disease-associated exposures, is considered an important contributor to EA pathogenesis. Several risk factors have been identified for EA and its precursor, Barrett’s esophagus (BE), including symptomatic reflux, obesity, and smoking. The role of inherited genetic susceptibility remains an area of active investigation. To explore whether germline variation related to inflammatory processes influences susceptibility to BE/EA, we used data from a genome-wide association study (GWAS) of 2,515 EA cases, 3,295 BE cases, and 3,207 controls. Our analysis included 7,863 single nucleotide polymorphisms (SNPs) in 449 genes assigned to five pathways: cyclooxygenase (COX), cytokine signaling, oxidative stress, human leukocyte antigen, and NFκB. A principal components-based analytic framework was employed to evaluate pathway-level and gene-level associations with disease risk. We identified a significant signal for the COX pathway in relation to BE risk (P=0.0059, FDR q=0.03), and in gene-level analyses found an association with MGST1 (microsomal glutathione-S-transferase 1; P=0.0005, q=0.005). Assessment of 36 MGST1 SNPs identified 14 variants associated with elevated BE risk (q<0.05). Of these, four were subsequently confirmed (P<5.5 × 10−5) in a meta-analysis encompassing an independent set of 1,851 BE cases and 3,496 controls. Three of these SNPs (rs3852575, rs73112090, rs4149204) were associated with similar elevations in EA risk. This study provides the most comprehensive evaluation of inflammation-related germline variation in relation to risk of BE/EA, and suggests that variants in MGST1 influence disease susceptibility

Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

Background: Many patients with asthma have type-2 airway inflammation, identified by the presence of biomarkers, including history of allergy, high blood eosinophil (EOS) count, and high fractional exhaled nitric oxide levels. Objective: To assess disease burden in relation to type-2 inflammatory biomarker status (history of allergy, blood EOS count, and fractional exhaled nitric oxide level) in patients with uncontrolled and controlled severe asthma in the NOVEL observational longiTudinal studY (NOVELTY) (NCT02760329). Methods: Asthma diagnosis and severity were physician-reported. Control was defined using Asthma Control Test score (uncontrolled &lt;20, controlled ≥20) and/or 1 or more severe physician-reported exacerbation in the previous year. Biomarker distribution (history of allergy, blood EOS count, and fractional exhaled nitric oxide level), symptom burden (Asthma Control Test score, modified Medical Research Council dyspnea scale), health status (St George's Respiratory Questionnaire score), exacerbations, and health care resource utilization were assessed. Results: Of 647 patients with severe asthma, 446 had uncontrolled and 123 had controlled asthma. Among those with uncontrolled asthma, 196 (44%) had 2 or more positive biomarkers, 187 (42%) had 1 positive biomarker, 325 (73%) had low blood EOS, and 63 (14%) were triple-negative. Disease burden was similarly high across uncontrolled subgroups, irrespective of biomarker status, with poor symptom control (Asthma Control Test score 14.9-16.6), impaired health status (St George's Respiratory Questionnaire total score 46.7-49.4), clinically important breathlessness (modified Medical Research Council grade ≥2 in 47.3%-57.1%), and 1 or more severe exacerbation (70.6%-76.2%). Conclusions: Type-2 inflammatory biomarkers did not differentiate disease burden in patients with severe asthma. Patients with low type-2 inflammatory biomarker levels have few biologic therapy options; their needs should be addressed

Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

Background: Many patients with asthma have type-2 airway inflammation, identified by the presence of biomarkers, including history of allergy, high blood eosinophil (EOS) count, and high fractional exhaled nitric oxide levels. Objective: To assess disease burden in relation to type-2 inflammatory biomarker status (history of allergy, blood EOS count, and fractional exhaled nitric oxide level) in patients with uncontrolled and controlled severe asthma in the NOVEL observational longiTudinal studY (NOVELTY) (NCT02760329). Methods: Asthma diagnosis and severity were physician-reported. Control was defined using Asthma Control Test score (uncontrolled = 20) and/or 1 or more severe physician-reported exacerbation in the previous year. Biomarker distribution (history of allergy, blood EOS count, and fractional exhaled nitric oxide level), symptom burden (Asthma Control Test score, modified Medical Research Council dyspnea scale), health status (St George's Respiratory Questionnaire score), exacerbations, and health care resource utilization were assessed. Results: Of 647 patients with severe asthma, 446 had uncontrolled and 123 had controlled asthma. Among those with uncontrolled asthma, 196 (44%) had 2 or more positive biomarkers, 187 (42%) had 1 positive biomarker, 325 (73%) had low blood EOS, and 63 (14%) were triple-negative. Disease burden was similarly high across uncontrolled subgroups, irrespective of biomarker status, with poor symptom control (Asthma Control Test score 14.9-16.6), impaired health status (St George's Respiratory Questionnaire total score 46.7-49.4), clinically important breathlessness (modified Medical Research Council grade >= 2 in 47.3%-57.1%), and 1 or more severe exacerbation (70.6%-76.2%). Conclusions: Type-2 inflammatory biomarkers did not differentiate disease burden in patients with severe asthma. Patients with low type-2 inflammatory biomarker levels have few biologic therapy options; their needs should be addressed